vs
Side-by-side financial comparison of Aeluma, Inc. (ALMU) and Ovid Therapeutics Inc. (OVID). Click either name above to swap in a different company.
Aeluma, Inc. is the larger business by last-quarter revenue ($1.3M vs $718.0K, roughly 1.8× Ovid Therapeutics Inc.). On growth, Ovid Therapeutics Inc. posted the faster year-over-year revenue change (844.7% vs -21.1%).
Aeluma, Inc. is a U.S.-headquartered technology firm focused on the design, development, and production of high-performance optoelectronic components and semiconductor products. Its core offerings include photonic sensors and laser diodes, serving the LiDAR, 5G/6G communication, industrial sensing, and automotive markets across North America and the Asia-Pacific region.
ALMU vs OVID — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3M | $718.0K |
| Net Profit | $-1.9M | — |
| Gross Margin | 27.8% | — |
| Operating Margin | -163.6% | — |
| Net Margin | -145.7% | — |
| Revenue YoY | -21.1% | 844.7% |
| Net Profit YoY | 36.0% | 204.4% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3M | $718.0K | ||
| Q3 25 | $1.4M | $132.0K | ||
| Q2 25 | — | $6.3M | ||
| Q1 25 | — | $130.0K | ||
| Q4 24 | — | $76.0K | ||
| Q3 24 | — | $173.0K | ||
| Q2 24 | — | $169.0K | ||
| Q1 24 | — | $148.0K |
| Q4 25 | $-1.9M | — | ||
| Q3 25 | $-1.5M | $-12.2M | ||
| Q2 25 | — | $-4.7M | ||
| Q1 25 | — | $-10.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-14.0M | ||
| Q2 24 | — | $8.5M | ||
| Q1 24 | — | $-11.7M |
| Q4 25 | 27.8% | — | ||
| Q3 25 | 49.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -163.6% | — | ||
| Q3 25 | -116.1% | -9487.1% | ||
| Q2 25 | — | -80.9% | ||
| Q1 25 | — | -9653.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -7645.1% | ||
| Q2 24 | — | -12140.2% | ||
| Q1 24 | — | -11768.2% |
| Q4 25 | -145.7% | — | ||
| Q3 25 | -107.8% | -9210.6% | ||
| Q2 25 | — | -74.7% | ||
| Q1 25 | — | -7873.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -8096.0% | ||
| Q2 24 | — | 5042.0% | ||
| Q1 24 | — | -7901.4% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.20 | ||
| Q2 24 | — | $0.12 | ||
| Q1 24 | — | $-0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $38.6M | $13.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $40.8M | $130.7M |
| Total Assets | $42.6M | $150.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.6M | $13.2M | ||
| Q3 25 | $25.9M | $20.6M | ||
| Q2 25 | — | $28.4M | ||
| Q1 25 | — | $21.1M | ||
| Q4 24 | — | $26.3M | ||
| Q3 24 | — | $15.0M | ||
| Q2 24 | — | $29.7M | ||
| Q1 24 | — | $30.8M |
| Q4 25 | $40.8M | $130.7M | ||
| Q3 25 | $40.9M | $44.7M | ||
| Q2 25 | — | $55.8M | ||
| Q1 25 | — | $59.3M | ||
| Q4 24 | — | $68.2M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | — | $88.9M | ||
| Q1 24 | — | $78.3M |
| Q4 25 | $42.6M | $150.9M | ||
| Q3 25 | $42.7M | $63.8M | ||
| Q2 25 | — | $77.4M | ||
| Q1 25 | — | $81.7M | ||
| Q4 24 | — | $92.2M | ||
| Q3 24 | — | $102.7M | ||
| Q2 24 | — | $118.1M | ||
| Q1 24 | — | $131.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-251.0K | $-38.3M |
| Free Cash FlowOCF − Capex | $-282.0K | — |
| FCF MarginFCF / Revenue | -22.2% | — |
| Capex IntensityCapex / Revenue | 2.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-251.0K | $-38.3M | ||
| Q3 25 | $-815.0K | $-12.9M | ||
| Q2 25 | — | $-4.8M | ||
| Q1 25 | — | $-10.3M | ||
| Q4 24 | — | $-56.0M | ||
| Q3 24 | — | $-15.0M | ||
| Q2 24 | — | $-14.3M | ||
| Q1 24 | — | $-16.7M |
| Q4 25 | $-282.0K | — | ||
| Q3 25 | $-1.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-56.0M | ||
| Q3 24 | — | $-15.0M | ||
| Q2 24 | — | $-14.3M | ||
| Q1 24 | — | $-16.7M |
| Q4 25 | -22.2% | — | ||
| Q3 25 | -74.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -73719.7% | ||
| Q3 24 | — | -8676.9% | ||
| Q2 24 | — | -8455.0% | ||
| Q1 24 | — | -11287.2% |
| Q4 25 | 2.4% | 0.0% | ||
| Q3 25 | 15.2% | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 93.4% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 20.1% | ||
| Q1 24 | — | 12.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1.67× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
